These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 30956121)

  • 21. MedGenMed Hematology/Oncology conference report--translational research: any danger lurking in its wake? Highlights from the 2003 annual meeting of the American Association for Cancer Research; July 11-14, 2003; Washington, DC.
    Mariani SM
    MedGenMed; 2003 Aug; 5(3):34. PubMed ID: 14600670
    [No Abstract]   [Full Text] [Related]  

  • 22. American Society of Clinical Oncology Annual Meeting 2019.
    Del Pozo Martín Y
    Lancet Haematol; 2019 Jul; 6(7):e349. PubMed ID: 31182415
    [No Abstract]   [Full Text] [Related]  

  • 23. New scale assesses benefits of cancer medicines.
    Bagcchi S
    Lancet Oncol; 2015 Jul; 16(7):e316. PubMed ID: 26051234
    [No Abstract]   [Full Text] [Related]  

  • 24. Systemic anti-cancer therapy-induced diarrhoea.
    Forde C
    Br J Hosp Med (Lond); 2017 Sep; 78(9):C135-C139. PubMed ID: 28898154
    [No Abstract]   [Full Text] [Related]  

  • 25. Cancer research in the United States: A critical review of current status and proposal for alternative models.
    Kantarjian HM; Prat F; Steensma DP; Kurzrock R; Stewart DJ; Sekeres MA; Leveque J
    Cancer; 2018 Jul; 124(14):2881-2889. PubMed ID: 29757456
    [No Abstract]   [Full Text] [Related]  

  • 26. [Paediatric oncology in Hungary].
    Schuler D
    Orv Hetil; 2012 May; 153(21):803-10. PubMed ID: 22617369
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Preface. Combining clinical, translational and basic cancer drug research: the 2008 CESAR annual meeting.
    Brockmoeller J; Sehrt D; Scheulen ME
    Int J Clin Pharmacol Ther; 2009 Jan; 47(1):30-2. PubMed ID: 19203530
    [No Abstract]   [Full Text] [Related]  

  • 28. 62nd ASH Annual Meeting and Exposition.
    Gourd K
    Lancet Oncol; 2021 Jan; 22(1):24. PubMed ID: 33316219
    [No Abstract]   [Full Text] [Related]  

  • 29. [Clinical practice guidelines for the adverse events in medical oncology].
    Isobe T; Hayashi M; Tsubata Y
    Nihon Rinsho; 2015 Feb; 73 Suppl 2():45-50. PubMed ID: 25831722
    [No Abstract]   [Full Text] [Related]  

  • 30. Selected new developments in oncology.
    Beijnen JH; Schellens JH
    Curr Clin Pharmacol; 2010 Aug; 5(3):140. PubMed ID: 20450478
    [No Abstract]   [Full Text] [Related]  

  • 31. Tyrannosaurus Rex revisited--will it survive?
    Eberhardt W
    Future Oncol; 2005 Apr; 1(2):141-3. PubMed ID: 16555983
    [No Abstract]   [Full Text] [Related]  

  • 32. Oncology: Getting physical.
    Dusheck J
    Nature; 2012 Nov; 491(7425):S50-1. PubMed ID: 23320286
    [No Abstract]   [Full Text] [Related]  

  • 33. Response Rate as an Approval End Point in Oncology: Back to the Future.
    Blumenthal GM; Pazdur R
    JAMA Oncol; 2016 Jun; 2(6):780-1. PubMed ID: 26913938
    [No Abstract]   [Full Text] [Related]  

  • 34. The relevance of pharmacology in clinical oncology practice. Pharmacology is (as yet) no relevant...
    McVie JG
    Ann Oncol; 1993 Jun; 4(6):465. PubMed ID: 8353086
    [No Abstract]   [Full Text] [Related]  

  • 35. The relevance of pharmacology in clinical oncology practice. The moderator thinks that...
    Workman P
    Ann Oncol; 1993 Jun; 4(6):466-9. PubMed ID: 8353087
    [No Abstract]   [Full Text] [Related]  

  • 36. The relevance of pharmacology in clinical oncology practice. Pharmacology is relevant.
    Gianni L
    Ann Oncol; 1993 Jun; 4(6):463-5. PubMed ID: 8353085
    [No Abstract]   [Full Text] [Related]  

  • 37. Medians and Milestones in Describing the Path to Cancer Cures: Telling "Tails".
    Hellmann MD; Kris MG; Rudin CM
    JAMA Oncol; 2016 Feb; 2(2):167-8. PubMed ID: 26583516
    [No Abstract]   [Full Text] [Related]  

  • 38. The American Society of Clinical Oncology guideline program.
    Winn RF; Smith TF
    Pharm Pract Manag Q; 1996 Apr; 16(1):31-8. PubMed ID: 10157738
    [No Abstract]   [Full Text] [Related]  

  • 39. Factors influencing development of new therapeutics for oncology.
    Winquist RJ; Boucher DM
    Curr Opin Pharmacol; 2010 Aug; 10(4):353-5. PubMed ID: 20634136
    [No Abstract]   [Full Text] [Related]  

  • 40. Optimizing oncology therapeutics through quantitative translational and clinical pharmacology: challenges and opportunities.
    Venkatakrishnan K; Friberg LE; Ouellet D; Mettetal JT; Stein A; Trocóniz IF; Bruno R; Mehrotra N; Gobburu J; Mould DR
    Clin Pharmacol Ther; 2015 Jan; 97(1):37-54. PubMed ID: 25670382
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.